Testing immune markers to predict outcomes in ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with suspected or confirmed ovarian cancer that may be primary or has come back
- Your doctor plans surgery and/or chemotherapy and/or immunotherapy for your cancer
- You can take part in treatment and follow-up visits and can share the needed information with the study team
- Your overall health is good enough for daily activities (performance status 0–2)
- You can sign informed consent (and any medical/mental situation would allow meaningful consent and study completion)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
This study looks at whether changes in immune system markers in the blood can help detect if ovarian cancer comes back after treatment. It tests standard chemotherapy and surgery, with the goal of improving how doctors monitor the disease.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This trial tests whether adding immunotherapy (a treatment that boosts your immune system) to surgery helps people whose ovarian cancer has returned and is sensitive to chemotherapy. It aims to see if this combination can improve outcomes for patients with certain biomarkers.
This study examines how to improve the immune system's response during ovarian cancer surgery, potentially helping the body fight the cancer better. It compares patients with ovarian cancer to women having surgery for non-cancerous conditions.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.